Peering into the aftermath: The inhospitable host? (Q54645085)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Peering into the aftermath: The inhospitable host?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

Peering into the aftermath: The inhospitable host? (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

author name string

Robert S Kerbel

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

John M L Ebos

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

16

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

10

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

1084-1085

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

https://scigraph.springernature.com/pub.10.1038/nm1010-1084

0 references

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers of response and resistance to antiangiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modes of resistance to anti-angiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20930748

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NM1010-1084

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20930748

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54645085&oldid=1407234036"